{
  "trial_id": "NCT00441818",
  "title": "Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma",
  "condition": "Hodgkin's Lymphoma",
  "participant_count": 59,
  "bias_type": "mixed",
  "age_distribution": {
    "mean": 50.0,
    "std": 14.570873166272028,
    "min": 18,
    "max": 80
  },
  "gender_distribution": {
    "male": 0.49626229567393165,
    "female": 0.5037377043260683
  },
  "ethnicity_distribution": {
    "white": 0.7,
    "black": 0.15,
    "asian": 0.1,
    "hispanic": 0.04,
    "other": 0.01
  },
  "sample_size": 59,
  "eligibility_score": 0.823622987870932
}